How pharmacological receptor theory can guide new drug discovery CCR5 HIV inhibitors in AIDS as a case study

Proceedings of the Western Pharmacology Society

Volumn 50, Issue , 2007, Pages 1-7

  Kenakin, Terry ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CCR5; DRUG RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; ARTICLE; DRUG DESIGN; DRUG EFFECT; DRUG SCREENING; GENETICS; HUMAN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTI-HIV AGENTS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; RECEPTORS, CCR5; RECEPTORS, DRUG;

EID: 48249134019     PISSN: 00838969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Kenakin, T.P. (2001) FASEB J. 15, 598-611.
2. Kenakin, T.P. (2002). Ann Rev of Pharmacol Toxicol 42, 349-379.
3. Galandrin S. and Bouvier M. (2006). Mol. Pharmacol. 70, 1575-1584.
4. Okada, T. and Palczewski, K. (2001) Curr. Opin. Struc. Biol. 11, 420-426.
5. Gether, U., Lin, S, and Kobilka, B.K. (1995) J. Biol. Chem. 270, 28268-28275.
6. Swaminath G., Xiang Y., Lee T.W., et al., (2004) J. Biol. Chem. 279, 686-691.
7. Ghanouni, P., Gryczynski, Z., Steenhuis, J.J., et al., (2001) J. Biol. Chem. 276, 24433-24436.
8. Palanche, T., Ilien, B., Zoffman, S., et al., (2001) J. Biol. Chem. 276, 34853-34861.
9. Seifert, R., Gether, U., Wenzel-Seifert, K. and Kobilka, B.K. (1999) Mol. Pharmacol. 56, 348-358.
10. Seifert, R., Wenzel-Seifert, K. and Kobilka, B.K. (1999) Trends Pharmacol. Sci. 20, 383-389.
11. Burgen A.S.V. (1966) Fed. Proc. 40, 2723-2728.
12. Kenakin, T.P. (2003) Nature Rev Drug Disc. 2, 429-437.
13. Kenakin, T.P. (1995) Trends Pharmacol. Sci. 16, 232-238.
14. Kenakin, T. P. (2003) Trends Pharmacol. Sci. 24, 346-354.
15. Kenakin, T.P. (2006) Expert Opin. Drug Disc. 1, 635-652.
16. Perez, D.M. and Karnik, S.S. (2005) Pharmacol Rev 57, 147-161.
17. Urban, J.D., Clarke W.P., von Zastrow M., et al., (2007) J. Pharmacol. Exp. Ther. 320, 1-13.
18. Azzi, M., Charest, P.G., Angers, S., et al., (2003) Proc. Natl. Acad. Sci. USA 100, 11406-11411.
19. Baker, J.G., Hall, I.P., Hill, S.J. (2003) Mol. Pharmacol. 64,1357-1369.
20. Feng, Z., Dubyak, G.R., Lederman, M.M., and Weinberg, A. (2006) J. Immunol. 177, 782-786.
21. Willins, D.L, Berry, S.A., Alsayegh, L., et al., (1999) Neurosci. 91,599-606.
22. Pastori, C., Weiser, B., Barassi, C., et al., (2006) Blood 107, 4825-4833.